Over 25 Years of Scientific Rigor & Clinical Excellence

OUR STORY & EVOLUTION

A Globally Recognized Canadian-Based Mid-Tier Powerhouse

Over the past decade, AstraClinical has navigated high-volume studies involving over 500,000 patients across 8,500 investigator hospital sites worldwide. We bridge the gap between large multinational biopharma sponsors and specialized academic medical centers.

Unlike massive bureaucratic CROs where mid-sized sponsors are deprioritized, our mid-tier niche positioning ensures direct C-suite oversight, agile protocol amendments, and committed project leadership from Phase I First-in-Human through Phase IV Real-World Evidence.